These receptors have also been reported to reduce the rate of atherosclerosis progression via NF-κB suppression that causes attenuation of pro-inflammatory cytokines production and inhibits cluster of differentiation (CD36) expression, thus reducing LDL absorption [57]. The gene discussed is NFKB1; the disease is atherosclerosis.